drugset / Trial / NCT00107445

EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer

NCT00107445

Phase 2 Completed 60 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelDiagnostic

Summary

This phase II trial is studying how well EF5 works in finding oxygen in tumor cells of patients who are undergoing surgery or biopsy for cervical, endometrial, or ovarian epithelial cancer. Diagnostic procedures using the drug EF5 to find oxygen in tumor cells may help in planning cancer treatment

Timeline

Start
2005-02
Primary completion
2005-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject EF5 Diagnostic / imaging agent Intravenous